Answers are grounded in this paper and cite their sources.
We examined the relationship between carboplatin dose and pattern of IHC and OHC loss in five groups of chinchillas treated with carboplatin: (I) single dose, 38 mg/kg, (II) double dose, 38 mg/kg, (III) double dose, 63 mg/kg, (IV) double dose, 75 mg/kg, and (V) double dose, 100 mg/kg. The pattern of IHC loss was relatively uniform along the length of the cochlea with all doses. Average IHC loss increased from approximately 20 per cent in group I to approximately 100 per cent in groups III, IV and V. Average OHC loss was small or negligible in groups I, II, III and IV; only group V consistently showed large (> 40 per cent) OHC losses. OHC loss progressed along a base-to-apex gradient. The dose of carboplatin which reliably destroyed OHCs was four to five times greater than that needed to damage IHCs.
No takes yet. Share an insight, caveat, or question.
Hofstetter et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: